$1.56
0.04 (+2.89%)
DUSA Pharmaceuticals, Inc. (DUSA)
CAPS Rating:
A dermatology company, which is engaged in the development and marketing Levulan photodynamic therapy and other products for common skin conditions.
No players have picked DUSA yet. Tell us why you think DUSA will outperform or underperform the S&P 500.
RSS Headlines
Fool UK
